Monogram Technologies to Showcase Precision Robotics at LD Micro Main Event XVII

Monogram Technologies Inc. (NASDAQ:MGRM), an AI-driven robotics company focusing on orthopedic surgery, announced its participation in the LD Micro Main Event XVII Conference on October 29-30, 2024, at the Luxe Sunset Blvd Hotel in Los Angeles. Chief Financial Officer Noel Knape will lead in-person meetings and a presentation on Monogram's innovative mBôs precision robotic surgical system.

The mBôs system is designed for autonomous, high-precision insertion of FDA-cleared mPress implants, aiming to improve total knee replacement outcomes. The presentation, scheduled for October 30 at 12:30 pm PT, will be accessible live and via replay through a webcast link, also available on Monogram's investor relations website.

The company seeks to combine 3D printing, AI, and robotics to create patient-optimized orthopedic implants. Monogram has FDA clearance for its mPress implants and is seeking clearance for its robotic products.